Literature DB >> 30100495

Adaptations of hepatic lipid metabolism and mitochondria in dairy cows with mild fatty liver.

Xiliang Du1, Taiyu Shen1, Heyuan Wang2, Xia Qin3, Dongmei Xing4, Qianqian Ye1, Zhen Shi1, Zhiyuan Fang1, Yiwei Zhu1, Yuchen Yang1, Zhicheng Peng1, Chenxu Zhao1, Bin Lv1, Xiaobing Li1, Guowen Liu5, Xinwei Li6.   

Abstract

The inevitable deficiency in nutrients and energy at the onset of lactation requires an optimal adaptation of the hepatic metabolism to overcome metabolic stress. Fatty liver is one of the main health disorders after parturition. Therefore, to investigate changes in hepatic lipid metabolic status and mitochondria in dairy cows with mild fatty liver, liver and blood samples were collected from healthy cows (n = 15) and cows with mild fatty liver (n = 15). To determine the effects of palmitic acids (PA), one of the major component of fatty acids, on lipid metabolism and mitochondria in vitro, calf hepatocytes were isolated from healthy calves and treated with various concentrations of PA (0, 50, 100, and 200 μM). Dairy cows with mild fatty liver displayed hepatic lipid accumulation. The protein levels of sterol regulatory element-binding protein 1c (SREBP-1c) and peroxisome proliferator-activated receptor-α (PPARα) and mRNA levels of acetyl CoA carboxylase 1 (ACC1), fatty acid synthase (FAS), acyl-CoA oxidase (ACO), and carnitine palmitoyltransferase 1A (CPT1A) were significantly higher in dairy cows with mild fatty liver than in control cows. The hepatic mitochondrial DNA content, mRNA levels of oxidative phosphorylation complexes I to V (CO 1-V), protein levels of cytochrome c oxidase subunit IV (COX IV), voltage dependent anion channel 1 (VDAC1), peroxisome proliferator activated receptor-γ coactivator-1α (PGC-1α) and nuclear respiratory factor 1 (NRF1), and adenosine triphosphate (ATP) content were all markedly increased in the liver of dairy cows with mild fatty liver compared with healthy cows. The PA treatment significantly increased lipid accumulation; protein levels of SREBP-1c and PPARα; and mRNA levels of ACC1, FAS, ACO, and CPT1A in calf hepatocytes. Moreover, the mitochondrial DNA content, mRNA levels of CO 1-V, protein levels of COX IV, VDAC1, PGC-1α, NRF1, mitochondrial transcription factor A, and ATP content were significantly increased in PA-treated hepatocytes compared with control hepatocytes. The protein level of mitofusin-2 was significantly decreased in PA-treated groups. In conclusion, lipid synthesis and oxidation, number of mitochondria, and ATP production were increased in the liver of dairy cows with mild fatty liver and PA-treated calf hepatocytes. These changes in hepatic mitochondria and lipid metabolism may be the adaptive mechanism of dairy cows with mild fatty liver.
Copyright © 2018 American Dairy Science Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  adaptation; dairy cow; lipid metabolism; mild fatty liver; mitochondria

Mesh:

Substances:

Year:  2018        PMID: 30100495     DOI: 10.3168/jds.2018-14546

Source DB:  PubMed          Journal:  J Dairy Sci        ISSN: 0022-0302            Impact factor:   4.034


  12 in total

1.  Cyanidin-3-O-glucoside improves non-alcoholic fatty liver disease by promoting PINK1-mediated mitophagy in mice.

Authors:  Xinwei Li; Zhen Shi; Yiwei Zhu; Taiyu Shen; Heyuan Wang; Guanghou Shui; Juan J Loor; Zhiyuan Fang; Meng Chen; Xinghui Wang; Zhicheng Peng; Yuxiang Song; Zhe Wang; Xiliang Du; Guowen Liu
Journal:  Br J Pharmacol       Date:  2020-06-14       Impact factor: 8.739

2.  Intracellular Ca2+ signaling and ORAI calcium release-activated calcium modulator 1 are associated with hepatic lipidosis in dairy cattle.

Authors:  Ming Li; Wei Yang; Jianan Wen; Juan J Loor; Ahmad Aboragah; Jingjing Wang; Shuang Wang; Mingyang Li; Liyun Yu; Xilin Hou; Chuang Xu; Bingbing Zhang
Journal:  J Anim Sci       Date:  2021-07-01       Impact factor: 3.338

3.  Effects of Ketosis in Dairy Cows on Blood Biochemical Parameters, Milk Yield and Composition, and Digestive Capacity.

Authors:  Wei Yang; Bingbing Zhang; Chuang Xu; Hongyou Zhang; Cheng Xia
Journal:  J Vet Res       Date:  2019-10-08       Impact factor: 1.744

4.  NEFAs Influence the Inflammatory and Insulin Signaling Pathways Through TLR4 in Primary Calf Hepatocytes in vitro.

Authors:  Qinghua Deng; Liyin Du; Yuming Zhang; Guowen Liu
Journal:  Front Vet Sci       Date:  2021-12-13

5.  The Role of Tea Tree Oil in Alleviating Palmitic Acid-Induced Lipid Accumulation in Bovine Hepatocytes.

Authors:  Tianyu Yang; Xiaoyu Ma; Maocheng Jiang; Zhiqiang Cheng; Osmond Datsomor; Guoqi Zhao; Kang Zhan
Journal:  Front Vet Sci       Date:  2022-01-21

6.  A Discovery of Relevant Hepatoprotective Effects and Underlying Mechanisms of Dietary Clostridium butyricum Against Corticosterone-Induced Liver Injury in Pekin Ducks.

Authors:  Yanhan Liu; Cun Liu; Liqing Huang; Zhaofei Xia
Journal:  Microorganisms       Date:  2019-09-16

7.  Hepatic metabolomics and transcriptomics to study susceptibility to ketosis in response to prepartal nutritional management.

Authors:  Khuram Shahzad; Vincenzo Lopreiato; Yusheng Liang; Erminio Trevisi; Johan S Osorio; Chuang Xu; Juan J Loor
Journal:  J Anim Sci Biotechnol       Date:  2019-12-18

8.  Metabolic alterations in dairy cows with subclinical ketosis after treatment with carboxymethyl chitosan-loaded, reduced glutathione nanoparticles.

Authors:  Chang Zhao; Yunlong Bai; Shixin Fu; Ling Wu; Cheng Xia; Chuang Xu
Journal:  J Vet Intern Med       Date:  2020-09-23       Impact factor: 3.333

9.  Lipid Accumulation and Injury in Primary Calf Hepatocytes Challenged With Different Long-Chain Fatty Acids.

Authors:  Bingbing Zhang; Wei Yang; Shuang Wang; Runqi Liu; Juan J Loor; Zhihao Dong; Yingying Zhao; Xinru Ma; Cheng Xia; Chuang Xu
Journal:  Front Vet Sci       Date:  2020-10-15

Review 10.  PGC-1α protects from myocardial ischaemia-reperfusion injury by regulating mitonuclear communication.

Authors:  Yan-Qing Li; Yan Jiao; Ya-Nan Liu; Jia-Ying Fu; Lian-Kun Sun; Jing Su
Journal:  J Cell Mol Med       Date:  2021-01-19       Impact factor: 5.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.